XTL Biopharmaceuticals (XTLB) Earnings Date, Estimates & Call Transcripts → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free XTLB Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisCompetitorsEarningsHeadlinesShort InterestSocial MediaStock AnalysisCompetitorsEarningsHeadlinesShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueXTLB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.XTLB Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchMove Your Money Before May 1Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens? Click here to get the full story before May 1. XTLB Earnings Date and InformationXTL Biopharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 21st, 2024 based off prior year's report dates.Read More Get XTL Biopharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for XTLB and its competitors with MarketBeat's FREE daily newsletter. XTL Biopharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/21/2024Estimated)------- 11/15/2023Q3 2023-($0.04)($0.04)($0.04)--8/10/2023Q2 2023-($0.07)($0.07)($0.07)--5/16/2023Q1 2023-($0.17)($0.17)($0.17)--3/22/2023Q4 2022-($0.14)($0.14)($0.14)--11/29/2022Q3 2022-($0.15)($0.15)($0.15)--8/24/2022Q2 2022-($0.10)($0.10)($0.10)-- Get the Latest News and Ratings for XTLB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for XTL Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 3/30/2022Q4 2021-$0.40+$0.40$0.40--11/24/2021Q3 2021-($0.10)($0.10)($0.10)--8/24/2021Q2 2021-($0.22)($0.22)($0.22)--5/19/2021Q1 2021-$0.05+$0.05$0.05-- XTL Biopharmaceuticals Earnings - Frequently Asked Questions When is XTL Biopharmaceuticals's earnings date? XTL Biopharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 21st, 2024 based off last year's report dates. Learn more on XTLB's earnings history. How much profit does XTL Biopharmaceuticals generate each year? XTL Biopharmaceuticals (NASDAQ:XTLB) has a recorded net income of -$1.35 million. XTLB has generated -$0.42 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Edesa Biotech Earnings Results Kiora Pharmaceuticals Earnings Results NanoViricides Earnings Results VBI Vaccines Earnings Results Cocrystal Pharma Earnings Results Imunon Earnings Results Monopar Therapeutics Earnings Results Tonix Pharmaceuticals Earnings Results Orgenesis Earnings Results Benitec Biopharma Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NASDAQ:XTLB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XTL Biopharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
